Apparent diffusion coefficient as an MR imaging biomarker of low-risk ductal carcinoma in situ: A pilot study

Radiology

Volumn 260, Issue 2, 2011, Pages 364-372

  Iima, Mami ^a,b   Le Bihan, Denis ^a,c   Okumura, Ryosuke ^b   Okada, Tomohisa ^a   Fujimoto, Koji ^a   Kanao, Shotaro ^a   Tanaka, Shiro ^d   Fujimoto, Masakazu ^b   Sakashita, Hiromi ^b   Togashi, Kaori ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kitano Hospital   (Japan)

^c CEA SACLAY   (France)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GADOTERIDOL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER GRADING; CANCER INVASION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INTRADUCTAL CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SIGNAL NOISE RATIO; TUMOR VOLUME;

ADULT; AGED; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HETEROCYCLIC COMPOUNDS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LINEAR MODELS; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 79960693358     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11101892     Document Type: Article

References (45)

1. Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 2002;94(20):1546-1554. (Pubitemid 35277278)
2. Erbas B, Provenzano E, Armes J, Gertig D. The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat 2006;97(2):135-144.
3. Sanders ME, Schuyler PA, Dupont WD, Page DL. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 2005;103(12):2481-2484. (Pubitemid 40800525)
4. Boecker W. Preneoplasia of the breast: a new conceptual approach to proliferative breast disease. Munich, Germany: Saunders Elsevier, 2006; 428.
5. Dinkel HP, Gassel AM, Tschammler A. Is the appearance of microcalcifications on mammography useful in predicting histological grade of malignancy in ductal cancer in situ? Br J Radiol 2000;73(873):938-944.
6. Kuhl C. The current status of breast MR imaging. I. Choice of technique, image interpre tation, diagnostic accuracy, and transfer to clinical practice. Radiology 2007;244(2):356-378.
7. Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004;233(3):830-849.
8. Neubauer H, Li M, Kuehne-Heid R, Schneider A, Kaiser WA. High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement. Br J Radiol 2003;76(901):3-12. (Pubitemid 36236293)
9. Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 2007;370(9586):485-492. (Pubitemid 47214635)
10. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986;161(2):401-407. (Pubitemid 17173295)
11. Le Bihan D. Molecular diffusion, tissue microdynamics and microstructure. NMR Biomed 1995;8(7-8):375-386.
12. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion-weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004;22(4):275-282. (Pubitemid 39264807)
13. Tamai K, Koyama T, Saga T, et al. The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 2008;18(4):723-730. (Pubitemid 351447778)
14. Tamai K, Koyama T, Saga T, et al. Diffusion-weighted MR imaging of uterine endometrial cancer. J Magn Reson Imaging 2007;26(3):682-687. (Pubitemid 350194592)
15. Le Bihan D. The "wet mind": water and functional neuroimaging. Phys Med Biol 2007;52(7):R57-R90.
16. Kuroki-Suzuki S, Kuroki Y, Nasu K, Nawano S, Moriyama N, Okazaki M. Detecting breast cancer with non-contrast MR imaging: combining diffusion-weighted and STIR imaging. Magn Reson Med Sci 2007;6(1):21-27.
17. Guo Y, Cai YQ, Cai ZL, et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002;16(2):172-178. (Pubitemid 34810055)
18. Woodhams R, Matsunaga K, Iwabuchi K, et al. Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 2005;29(5):644-649. (Pubitemid 41395779)
19. Woodhams R, Matsunaga K, Kan S, et al. ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 2005;4(1):35-42.
20. Partridge SC, Demartini WB, Kurland BF, Eby PR, White SW, Lehman CD. Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI. J Magn Reson Imaging 2010;31(3):562-570.
21. Silverstein M, Lagios M, Craig P, et al. The Van Nuys prognostic index for ductal carcinoma in situ. Breast J 1996;2(1):38-40.
22. Silverstein MJ, Lagios MD, Craig PH, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996;77(11):2267-2274. (Pubitemid 26162419)
23. Bianchi S, Vezzosi V. Microinvasive carcinoma of the breast. Pathol Oncol Res 2008;14(2):105-111.
24. Jansen SA, Newstead GM, Abe H, Shimauchi A, Schmidt RA, Karczmar GS. Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. Radiology 2007;245(3):684-691. (Pubitemid 350127338)
25. Tavassoli FA, Devilee P, eds. World Health Organization classification of tumours: pathology and genetics of tumours of the breast and female genital organs. Lyon, France: IARC Press, 2003.
26. SAS Institute. SAS/STAT user's guide, version 9.2. Cary, NC: SAS Institute, 2009.
27. Allegra CJ, Aberle DR, Ganschow P, et al. NIH state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ (DCIS). NIH Consens State Sci Statements 2009;26(2):1-27.
28. Silverstein MJ, Rosser RJ, Gierson ED, et al. Axillary lymph node dissection for intraductal breast carcinoma - is it indicated? Cancer 1987;59(10):1819-1824.
29. Baxter NN, Virnig BA, Durham SB, Tuttle TM. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 2004;96(6):443-448. (Pubitemid 38443647)
30. Kitis O, Altay H, Calli C, Yunten N, Akalin T, Yurtseven T. Minimum apparent diffusion coefficients in the evaluation of brain tumors. Eur J Radiol 2005;55(3):393-400. (Pubitemid 41215567)
31. Sugahara T, Korogi Y, Kochi M, et al. Usefulness of diffusion-weighted MRI with echoplanar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999;9(1):53-60. (Pubitemid 29068231)
32. Yoshikawa MI, Ohsumi S, Sugata S, et al. Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med 2008;26(4):222-226. (Pubitemid 351754726)
33. Maffuz A, Barroso-Bravo S, Nájera I, Zarco G, Alvarado-Cabrero I, Rodríguez-Cuevas SA. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ. J Exp Clin Cancer Res 2006;25(2):223-227. (Pubitemid 44113867)
34. Partridge SC, Mullins CD, Kurland BF, et al. Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size. AJR Am J Roentgenol 2010;194(6):1664-1673.
35. Doskaliyev A, Yamasaki F, Ohtaki M, et al. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b -value diffusion-weighted magnetic resonance imaging at 3T. Eur J Radiol 2010. doi:10.1016/j.ejrad.2010.11.005. Published December 1, 2010.
36. Vlastos G, Verkooijen HM. Minimally invasive approaches for diagnosis and treatment of early-stage breast cancer. Oncologist 2007;12(1):1-10. (Pubitemid 46143498)
37. Kettritz U. Modern concepts of ductal carcinoma in situ (DCIS) and its diagnosis through percutaneous biopsy. Eur Radiol 2008;18(2):343-350. (Pubitemid 351234055)
38. Yabuuchi H, Matsuo Y, Okafuji T, et al. Enhanced mass on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. J Magn Reson Imaging 2008;28(5):1157-1165.
39. Woodhams R, Kakita S, Hata H, et al. Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging - comparison with contrast-enhanced MR imaging and pathologic findings. Radiology 2010;254(2):357-366.
40. Bogner W, Gruber S, Pinker K, et al. Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? Radiology 2009;253(2):341-351.
41. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351(5):427-437.
42. Gill JK, Maskarinec G, Pagano I, Kolonel LN. The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort. Breast Cancer Res 2006;8(3):R30.
43. Park MJ, Cha ES, Kang BJ, Ihn YK, Baik JH. The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J Radiol 2007;8(5):390-396.
44. Pediconi F, Padula S, Dominelli V, et al. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation. Radiology 2010;257(3):653-661.
45. Kennedy F, Harcourt D, Rumsey N, White P. The psychosocial impact of ductal carcinoma in situ (DCIS): a longitudinal prospective study. Breast 2010;19(5):382-387.